ACE inhibition and glomerular repair: Restructuring or regeneration?

Kidney International

Volumn 69, Issue 7, 2006, Pages 1105-1107

  Joles, J A ^a   Braam, B ^a   Verhaar, M C ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AMINONUCLEOSIDE; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; ANGIOTENSIN II; ANGIOTENSINOGEN; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; NITRIC OXIDE SYNTHASE; PUROMYCIN; RENIN;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; CREATININE BLOOD LEVEL; DIABETIC NEPHROPATHY; DRUG EFFECT; ENDOTHELIUM CELL; ENZYME INHIBITION; GLOMERULONEPHRITIS; GLOMERULOSCLEROSIS; GLOMERULUS; HYPERTENSION; IMAGE RECONSTRUCTION; INSULIN DEPENDENT DIABETES MELLITUS; KIDNEY DISEASE; KIDNEY FUNCTION; MALE; NEPHRECTOMY; NONHUMAN; PRIORITY JOURNAL; PROTEINURIA; RAT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; THREE DIMENSIONAL IMAGING;

EID: 33645533491     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/sj.ki.5000237     Document Type: Note

References (15)

1. Ruggenenti P, Schieppati A, Remuzzi G. Progression, remission, regression of chronic renal diseases. Lancet 2001; 357: 1601-1608.
2. Remuzzi A, Fassi A, Bertani T et al. ACE inhibition induces regression of proteinuria and halts progression of renal damage in a genetic model of progressive nephropathy. Am J Kidney Dis 1999; 34: 626-632.
3. Adamczak M, Gross ML, Amann K, Ritz E. Reversal of glomerular lesions involves coordinated restructuring of glomerular microvasculature. J Am Soc Nephrol 2004; 15: 3063-3072.
4. Remuzzi A, Gagliardini E, Sangalli F et al. ACE inhibition reduces glomerulosclerosis and regenerates glomerular tissue in a model of progressive renal disease. Kidney Int 2006; 69: 1124-1130.
5. Verseput GH, Provoost AP, Braam B et al. Angiotensin-converting enzyme inhibition in the prevention and treatment of chronic renal damage in the hypertensive fawn-hooded rat. J Am Soc Nephrol 1997; 8: 249-259.
6. Fabre JE, Rivard A, Magner M et al. Tissue inhibition of angiotensin-converting enzyme activity stimulates angiogenesis in vivo. Circulation 1999; 99: 3043-3049.
7. Rookmaaker MB, Smits AM, Tolboom H et al. Bone-marrow-derived cells contribute to glomerular endothelial repair in experimental glomerulonephritis. Am J Pathol 2003; 163: 553-562.
8. Imanishi T, Hanoi, Nishio I. Angiotensin II accelerates endothelial progenitor cell senescence through induction of oxidative stress. J Hypertens 2005; 23: 97-104.
9. Bahlmann FH, de Groot K, Mueller O et al. Stimulation of endothelial progenitor cells: a new putative therapeutic effect of angiotensin II receptor antagonists. Hypertension 2005; 45: 526-529.
10. Racasan S, Hahnel B, van der Giezen DM et al. Temporary losartan or captopril in young SHR induces malignant hypertension despite initial normotension. Kidney Int 2004; 65: 575-581.
11. Pentz ES, Moyano MA, Thornhill BA et al. Ablation of renin-expressing juxtaglomerular cells results in a distinct kidney phenotype. Am J Physiol Regul Integr Comp Physiol 2004; 286: R474-R483.
12. Mattot V, Moons L, Lupu F et al. Loss of the VEGF(164) and VEGF(188) isoforms impairs postnatal glomerular angiogenesis and renal arteriogenesis in mice. J Am Soc Nephrol 2002; 13: 1548-1560.
13. Smit-van Oosten A, Navis G, Stegeman CA et al. Chronic blockade of angiotensin II action prevents glomerulosclerosis, but induces graft vasculopathy in experimental kidney transplantation. J Pathol 2001; 194: 122-129.
14. Takazawa Y, Maeshima Y, Kitayama H et al. Infusion of angiotensin II reduces loss of glomerular capillary area in the early phase of anti-Thy-1.1 nephritis possibly via regulating angiogenesis-associated factors. Kidney Int 2005; 68: 704-722.
15. Ebrahimian TG, Tamarat R, Clergue M et al. Dual effect of angiotensin-converting enzyme inhibition on angiogenesis in type 1 diabetic mice. Arterioscler Thromb Vasc Biol 2005; 25: 65-70.